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Purpose: Clostridium difficile (C. difficile)-associated colitis, a known complication of colon and rectal surgery, can increase 
perioperative morbidity and mortality, leading to increased hospital stay and costs. Several contributing factors, including 
advanced age, mechanical bowel preparation, and antibiotics, have been implicated in this condition. The purpose of this 
study was to determine the clinical features of and factors responsible for C. difficile-associated colitis after colorectal can-
cer surgery. 
Methods: The medical records of patients who had undergone elective resection for colorectal cancer from January 2008 to 
April 2010 were reviewed. Cases that involved procedures such as transanal excision, stoma creation, or emergency opera-
tion were excluded from the analysis. 
Results: Resection with primary anastomosis was performed in 219 patients with colorectal cancer. The rate of postopera-
tive C. difficile-associated colitis was 6.8% in the entire study population. Preoperative metallic stent insertion (P = 0.017) 
and aged sixty and older (≥ 60, P = 0.025) were identified as risk factors for postoperative C. difficile-associated colitis. There 
were no significant differences in variables such as preoperative oral non-absorbable antibiotics, site of operation, opera-
tion procedure, and duration of prophylactic antibiotics. 
Conclusion: Among the potential causative factors of postoperative C. difficile-associated colitis, preoperative metallic stent 
insertion and aged sixty and older were identified as risk factors on the basis of our data. Strategies to prevent C. difficile 
infection should be carried out in patients who have undergone preoperative insertion of a metallic stent and are aged sixty 
and older years.
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features of C. difficile-associated colitis are diverse, ranging 
from mild diarrhea to pseudomembranous-colitis-induced 
fever, abdominal pain, abdomen distention, leukocytosis, and 
fulminant colitis causing hemorrhage and necrosis [1-3]. 
As risk factors for C. difficile-associated colitis, old age, im-
paired immune function, intestinal retention, renal failure, 
chemotherapy, and surgery itself in the gastrointestinal sys-
tem have been reported [4, 5]. Particularly, the normal bacte-
rial flora in the intestine has been shown to be destroyed by 
the use of antibiotics; thus, C. difficile forms colonies in the 
intestine and causes C. difficile-associated colitis. In addition, 
preoperative mechanical bowel preparation performed prior 
to surgery for colorectal cancer, the use of oral antibiotics and 
prophylactic intravenous antibiotics, and the proctocolectomy 
itself change the normal bacterial flora in the intestine; hence, 
they have been shown to be risk factors. Nonetheless, system-
atized reports are rare [6-9]. Therefore, we examined the clin-
INTRODUCTION
Clostridium difficile (C. difficile)-associated colitis is acute in-
fectious colitis caused by the toxin of the abnormally prolifer-
ated anaerobe gram positive bacteria C. difficile. The clinical 
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ical features of and the risk factors for C. difficile-associated 
colitis after colorectal cancer surgery. 
METHODS
The study was conducted on 219 patients diagnosed as having 
colorectal cancer and treated with a radical resection and pri-
mary anastomosis at our hospital from January 2008 to April 
2010. Patients without a primary anastomosis, such as those 
with stomy creation and transanal operation, were excluded, 
and patients on whom emergency surgery without bowel prep-
aration had been performed were excluded. In all patients, 
mechanical bowl preparation was performed 1 or 2 days prior 
to surgery with either 90 mL of Fleet phospho-soda
® (sodium 
phosphate; Merck Frosst Canada Inc., Kirkland, QU, Canada) 
or 4 L of Colyte-F
® (polyethylene glycol, PEG; Taejoon Pharm, 
Seoul, Korea). From January 2008 to February 2009, patients 
were treated with oral antibiotics prior to surgery; after that 
date, oral antibiotics were not used. As oral antibiotics, one day 
before surgery, at 12 pm, 6 pm, and 10 pm, kanamycin and 
metronidazole were taken. As prophylactic intravenous anti-
biotics, in all patients, the second generation cephalosporin 
antibiotic Pacetin
® (cefoxitin; Choongwae Pharm Co., Seoul, 
Korea) 2 g was injected intravenously 30 minutes before skin 
incision. For the maintenance of intravenous antibiotics, ac-
cording to intraoperative findings, antibiotics were empirically 
administered from one injection to up to for 5 days. Patients 
were diagnosed as having C. difficile-associated colitis when 
the clinical symptoms of watery diarrhea more than 3 times 
per day, fever, abdominal pain, abdominal distention, leuko-
cytosis, and positive C. difficile toxin were present. 
For statistical analysis, the SPSS ver. 17.0 (SPSS Inc., Chicago, 
IL, USA) statistics program was used. For the comparative 
analysis of variables, the chi-square test or the Fisher’s exact 
test was applied. As statistical significance, cases with P-values 
lower than 0.05 were considered to be significant. 
RESULTS
The mean age of the 219 colorectal cancer patients was 64.7 
years (range, 28 to 84 years), 120 patients were male, and 99 
patients were female. The primary lesion site was the right side 
colon in 71 patients (32.5%), the left side colon in 103 patients 
(46.9%), and the rectum in 45 patients (20.6%). Among patients 
who underwent surgery for colorectal cancer, 15 patients were 
diagnosed as having C. difficile-associated colitis, and the in-
cidence was 6.8%. 
The mean age of patients diagnosed as having C. difficile-as-
sociated colitis was 70.8 years (range, 62 to79 years), and the 
ratio of males to females was 2:1 (Table 1). The mean interval 
from surgery to the manifestation of colitis symptoms was 8.2 
days (range, 6 to 15 days). The mean hospital stay of these pa-
tients was 18.1 days (range, 12 to 26 days). As clinical features, 
Table 1. Clinical characteristics of patients with Clostridium difficile-
associated colitis (n = 15)
Variables No. of patients (%)
Age (yr)
a  70.8 (62-79)
Sex
   Male
   Female
 10 (66.7)
   5 (33.3)
Onset time of Clostridium difficile -associated colitis (day)
a 8.2 (6-15)
Hostpital stay (day)
a 18.1 (12-26)
Clinical findings
   Diarrhea
   Fever
   Abdominal pain
   Leukocytosis
15 (100)
   8 (53.3)
3 (20)
   8 (53.3)
Treatment
   Oral metronidazole
   Conservative
 11 (73.3)
   4 (26.7)
aValues are presented as mean (range).
Table 2. Risk factors for Clostridium difficile-associated colitis 
Variables
C. difficile
P- 
value
C.difficile 
negative (%) 
(n = 204)
C.difficile 
positive (%) 
(n = 15)
Mean age, yr  64.2 (28-84)  70.8 (62-79) 0.000 
Age (yr)
a
   < 60 
   ≥ 60 
    53 (100)
  151 (91.0)
  0 (0.0)
15 (9.0)
0.025
  
 Sex
   Male
   Female 
110 (91.7)
  94 (94.9)
10 (8.3)
  5 (5.1)
0.425 
Preoperative oral non-absorbable 
antibiotics
   Yes
   No  
102 (92.7)
102 (93.6)
  8 (7.3)
  7 (6.4)
0.803
 
Site of operation 
   Right colon
   Left colon
   Rectum
  67 (95.7)
  99 (92.5)
  38 (90.5)
  3 (4.3)
  8 (7.5)
  4 (9.5)
0.560
 
 
Operation procedure 
   Open   
   Laparoscopy
  90 (94.7)
114 (91.9)
  5 (5.3)
10 (8.1)
0.438
 
 
Duration of prophylactic antibiotics use
   Postoperative single-dose
   > Postoperative single-dose 
  27 (96.4)
177 (92.7)
  1 (3.6)
14 (7.3)
0.699
 
Preoperative metallic stent insertion  
   Yes
   No
    6 (66.7)
198 (94.3)
    3 (33.3)
12 (5.7)
0.017
 
aValues are presented as mean (range).Journal of The Korean Society of
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5 patients (33.3%) showed only diarrhea without systemic symp-
toms, and 10 patients (66.7%) presented with fever, abdomi-
nal pain, and leukocytosis. 
As treatments for C. difficile-associated colitis, administra-
tion of oral metronidazole was used for 11 patients (73.3%), 
and the remaining 4 patients were not treated with oral anti-
biotics; only conservative treatments were performed. None 
of the patients developed complications. 
Comparing C. difficile-associated colitis patients and the con-
trol patients, gender was not statistically different (Table 2). 
The mean age of the control group was 64.2 years, and it was 
significantly higher in the colitis patient group (P = 0.000). In 
patients younger than 60 years, C. difficile-associated colitis 
was not observed. The incidence of C. difficile-associated coli-
tis in patients older than 60 years was higher, and this differ-
ence was statistically significant (P = 0.025).
Prior to surgery, oral antibiotics were used in 110 patients 
(50.2%), and the development of C. difficile-associated colitis 
for those patients was not significantly different from that for 
the control group. Regarding the primary lesion, C. difficile-
associated colitis developed slightly more in surgery involving 
the rectum, but that difference was not statistically significant. 
Regarding surgical methods, no differences between laparo-
scopic surgery and open were detected. The duration of the use 
of prophylactic intravenous antibiotics was examined, and no 
significant difference between the patient group and the con-
trol group was detected. In 9 patients (4.1%), because of the 
obstruction caused by colorectal cancer, surgery was performed 
after inserting a stent, and the stent insertion was shown to be 
a significant risk factor for the development of colitis (P = 0.017). 
A multivariate analysis was performed, and the insertion of a 
stent due to an obstruction by colorectal cancer was shown to 
be an independent risk factor (P = 0.001).  
DISCUSSION
C. difficile-associated colitis is colitis caused by the toxin of the 
anaerobic gram positive bacteria C. difficile, it usually occurs 
as a nosocomial infection, and the incidence has been reported 
to be 2.3-7.8% [1, 10, 11]. It may develop in patients who have 
undergone surgery. It particularly shows a high incidence in 
patients who have undergone surgery involving the gastroin-
testinal tract, and the incidence after a colorectal resection has 
been reported to be up to 21% [5]. The incidence of C. difficile-
associated colitis after colorectal resection, as assessed in our 
study, was 6.8%.
Clinical courses of infection caused by C. difficile are from 
asymptomatic carriers to patients with diarrhea, pseudomem-
branous colitis, or fulminant colitis such as toxic megacolon 
[12]. In many patients, it is asymptomatic or limited to mild 
diarrhea; 25% of the cases show pseudomembranous colitis, 
and it progresses to fulminant colitis in 1-3% of the cases [2, 
13]. The diarrhea pattern has been reported to be primarily 
watery diarrhea rather than bloody diarrhea, and it develops 
within 48-72 hours after infection. In our study, the mean in-
terval from surgery to the manifestation of colitis symptoms 
was 8.2 days (range, 6 to 15 days). 
In fulminant colitis cases, although rare, bowel perforation, 
toxic megacolon, and other complications may develop, and 
most patients experience associated abdominal pain, abdomi-
nal distention, hypotension, fever, and leukocytosis. As its treat-
ment, surgery is required, and mortality reaches 35-80%; thus, 
rapid diagnosis and treatment are required [14]. Rubin et al. [2] 
reported that in C. difficile-associated colitis patients, 3% of the 
patients show severe clinical courses, and they require inten-
sive treatment and may die. Symptoms more frequently pre-
sented in cases of severe C. difficile-associated colitis are ab-
dominal pain, abdominal distention, and leukocytosis. In ad-
dition, as risk factors for severe colitis, tumors, chronic ob-
structive pulmonary disease, impairment of immune function, 
anti-peristaltic drugs, and renal impairment have been reported. 
Nonetheless, diarrhea, abdominal pain, and fever are symp-
toms that frequently develop after surgery for colorectal can-
cer due to various causes, and their differentiation is difficult. 
In our cases, 5 patients (33.3%) developed diarrhea without 
systemic symptoms, and 10 patients (66.7%) had systemic symp-
toms, such as fever, abdominal pain, and leukocytosis; none-
theless, none of the patients showed severe colitis. As treat-
ments for patients showing watery diarrhea, the use of all an-
tibiotics was terminated, and a stool test was performed; for 
patients positive for C. difficile toxin, treatments were initiated.
As risk factors for C. difficile-associated colitis, old age, im-
paired immune function, intestinal retention, renal failure, 
chemotherapy, gastrointestinal surgery, and the use of antibi-
otics have been reported [4, 5, 15], and recently, proton pump 
inhibitors and quinolone antibiotics have been reported [16, 
17]. In addition, preoperative mechanical bowel preparation 
for colorectal cancer, the use of oral antibiotics, intravenous 
antibiotics, and the proctocolectomy itself have been reported 
to change the normal bacterial flora of the intestine and are 
thus risk factors for C. difficile-associated colitis [6-9]. 
Since Clarke et al. [7] reported in 1977 that in colorectal sur-
gery, mechanical bowel preparation and the use of antibiotics 
during surgery reduced bacterial infection and consequently 
postsurgical infectious complications, mechanical bowel prep-
aration and prophylactic antibiotics have been used until now. 
Recently, however, the necessity of the use of mechanical bowel 
preparation and the use of oral antibiotics has been questioned 
[9, 18]. Most studies regarding mechnical bowel preparation 
and the use of antibiotics have looked at the infectious com-
plications and anastomotic leakage, but studies on C. difficile-
associated colitis are rare. Wren et al. [19] reported that during 
colorectal surgery, the use of oral antibiotics induced a change 
in the normal bacterial flora of the large intestine, thus increas-Journal of The Korean Society of
Coloproctology
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ing the incidence of C. difficile-associated colitis. In our study, 
mechanical bowel preparation was performed on all patients, 
oral antibiotics were used in 110 patients (50.2%), and no oral 
antibiotics were used in the remaining 109 patients (49.8%). 
No significant differences in the development of colitis were 
observed between patients receiving oral antibiotics and those 
not receiving oral antibiotics. 
Age has been reported to be an independent risk factor for 
C. difficile-associated colitis in many studies. McFarland et al. 
[20] reported in a prospective study that age was an important 
risk factor. Similarly, McDonald et al. [21] reported that ac-
cording to age, differences in the development of C. difficile-
associated colitis were observed; particularly, in patients older 
than 65 years old, the incidence of C. difficile infection was 
high. In our study, age older than 60 years was shown to be a 
significant risk factor for C. difficile-associated colitis. How-
ever, in the multivariate analysis, age was not an independent 
risk factor. 
The use of antibiotics, particularly the third-generation ceph-
alosporin antibiotics, has been reported to be an important 
risk factor for C. difficile infection, and to limit their use is the 
most effective measure to prevent C. difficile infection [22]. In 
addition, penicillin, aminoglycoside, clindamycin, fluoroqui-
nolone, and other antibiotics have been reported to be associ-
ated with C. difficile infection [23, 24]. Kent et al. [5] reported 
that among several antibiotics, the use of cefoxitin was a risk 
factor for C. difficile-associated colitis. Metzger et al. [25] re-
ported that the incidence of C. difficile-associated diarrhea 
was high in the elderly, but no significant differences among 
antibiotics were detected. In our study, only the second-gen-
eration cephalosporin antibiotic Pacetin
® was used in all pa-
tients; thus, no analysis of the effect of the type of antibiotic 
could be performed.
The development of C. difficile-associated colitis has been 
reported to be generally related to long-term antibiotics treat-
ment. However, infection after using an antibiotic only once 
or for a short term has been reported. Hence, the duration of 
the exposure to antibiotics is a subject of controversy. Park et 
al. [26] reported that in patients who underwent gastrointes-
tinal surgery, the duration of the use of aminoglycoside anti-
biotics was an independent risk factor for the development of 
pseudomembranous colitis. In our study, the effect of the du-
ration of use of antibiotics was analyzed by dividing the dura-
tion of use of prophylactic antibiotics based on use once after 
surgery, and no significant differences were observed. Gener-
ally, the use of prophylactic antibiotics once after surgery is 
sufficient, and the duration of its use is determined by the half-
life of the antibiotic, the operation time, and the occurrence 
of contamination during surgery. Nonetheless, at our hospital, 
because of the burden of infectious complications, the dura-
tion of actual use is extended to up to 5 days.
Colorectal surgery has been reported to be a risk factor for 
C. difficile-associated colitis in many studies. Keighley et al. 
[27] reported that among patients receiving gastrointestinal 
surgery, the incidence of C. difficile-associated colitis was high 
in patients undergoing a colorectal resection. Kent et al. [5] 
examined 374 surgery patients and reported that the incidence 
of C. difficile-associated colitis was 5.6%. They reported that 
among them, 21% of the patients who underwent colorectal 
surgery and 29% of the patients who underwent surgery for 
small bowel and large bowel obstruction, C. difficile-associated 
colitis developed; in addition, intestinal retention was an in-
dependent risk factor. In our study, insertion of stents for 
colorectal cancer obstruction prior to surgery was confirmed 
to be an independent risk factor for the development of C. 
difficile-associated colitis. Obstruction of the large bowel, as 
well as the small bowel, is thought to cause a change in the 
normal bacterial flora of the intestine, which has an effect on 
the development of C. difficile-associated colitis. In the analy-
sis according to the site of the colorectal resection, the ten-
dency was that in patients undergoing surgery for rectal can-
cer, the incidence of C. difficile-associated colitis was slightly 
high, but no statistical significance was shown.
In regard to treatments for C. difficile-associated colitis, until 
now, metronidazole and vancomycin have been reported to be 
effective therapeutics [28]. However, according to recent studies, 
the treatment efficacy of metronidazole, known to be a first-
line treatment therapeutic, is worse than before. The reasons 
have been reported to be the aging of patients, an increase in 
the severity of underlying diseases, and the use of broad spec-
trum antibiotics, such as quinolone. In our cases, as treatments 
for C. difficile-associated colitis, oral metronidazole was admin-
istered to 11 patients (73.3%), and for the remaining 4 patients, 
no antibiotics were administered; only conservative treatments 
were performed. None of patients progressed to pseudomem-
branous colitis or fulminant colitis, and all patients were cured 
without complications. 
In conclusion, clinical symptoms of C. difficile-associated 
colitis, which develops in high incidence in patients undergo-
ing colorectal surgery, were diverse, and it was difficult to dif-
ferentiate the patients (for C. difficile-associated colitis) based 
solely on symptoms. In addition, C. difficile-associated colitis 
may prolong the hospital stay after surgery and increase cost, 
and it could influence morbidity and mortality. Thus, early 
diagnosis and treatment of C. difficile-associated colitis is con-
sidered to be important.
C. difficile-associated colitis occurs at high rates after colorec-
tal surgery. Risk factors are the insertion of stents prior to sur-
gery and an age older than 60 years. Therefore, in patients un-
dergoing surgery for colorectal cancer, if the symptoms of di-
arrhea, abdominal pain, fever, and leukocytosis are observed, 
keeping in mind the possibility of C. difficile-associated colitis, 
rapid diagnosis and treatments should be achieved. Particu-
larly, for elderly patients older than 60 years and patients who Journal of The Korean Society of
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had stents inserted prior to surgery for large bowel obstruc-
tion, strategies to prevent C. difficile infection are required.
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